WHO

As a non-state actor in official relations with the World Health Organization (WHO), FDI delivered six statements at the WHO Executive Board, pressing for further commitments on oral health.

The 71st World Health Assembly reviewed a diverse range of health topics with notable deliberations on issues affecting healthcare professionals and noncommunicable diseases (NCDs). FDI delivered statements on the preparation for the upcoming UN High-level meeting on NCDs; using digital applications (mHealth) to enhance public health outcomes; and maternal, infant and young child nutrition.

The 142nd session of the World Health Organization (WHO) Executive Board had noncommunicable diseases featured prominently on the agenda.

FDI’s message to the global health community: governments should include dental associations in the development of antimicrobial resistance actions plans; funding should be allocated for oral health to prevent oral disease in the context of noncommunicable diseases; and oral health should be integrated into the 2030 Agenda where FDI’s measurement tool, once developed, will be key to monitoring oral health outcomes.